{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:45:18Z","timestamp":1791089118372,"version":"4.1.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T00:00:00Z","timestamp":1403049600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0100220","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T00:04:37Z","timestamp":1403136277000},"page":"e100220","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":71,"title":["Failure of Miltefosine Treatment for Visceral Leishmaniasis in Children and Men in South-East Asia"],"prefix":"10.1371","volume":"9","author":[{"given":"Bart","family":"Ostyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Epco","family":"Hasker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P. C.","family":"Dorlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Rijal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Dujardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Boelaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,6,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"PJ Guerin","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"126093","DOI":"10.1155\/2012\/126093","article-title":"Visceral leishmaniasis clinical management in endemic districts of India, Nepal, and Bangladesh","volume":"2012","author":"MR Banjara","year":"2012","journal-title":"J Trop Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"SL Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/tmi.12092","article-title":"Retrospective Quarterly Cohort Monitoring for patients with Visceral Leishmaniasis in the Indian subcontinent: outcomes of a pilot project","volume":"18","author":"B Ostyn","year":"2013","journal-title":"Trop Med Int Health"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-3156.2011.02803.x","article-title":"Monitoring drug effectiveness in kala azar in Bihar, India: cost and feasibility of periodic random surveys vs. a health service-based reporting system","volume":"16","author":"P Malaviya","year":"2011","journal-title":"Trop Med Int Health"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1365-3156.2012.03097.x","article-title":"Cohort monitoring of persons with diabetes mellitus in a primary healthcare clinic for Palestine refugees in Jordan","volume":"17","author":"A Khader","year":"2012","journal-title":"Trop Med Int Health"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1365-3156.2012.03048.x","article-title":"Cohort monitoring of persons with hypertension: an illustrated example from a primary healthcare clinic for Palestine refugees in Jordan","volume":"17","author":"A Khader","year":"2012","journal-title":"Trop Med Int Health"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance","volume":"56","author":"S Rijal","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"S Sundar","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4269\/ajtmh.13-0096","article-title":"In vitro susceptibility of Leishmania donovani to Miltefosine in Indian Visceral Leishmaniasis","volume":"89","author":"VK Prajapati","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/bmj.308.6924.307","article-title":"Clinicoepidemiological study of drug resistance in Indian kala-azar","volume":"308","author":"S Sundar","year":"1994","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e705","DOI":"10.1371\/journal.pntd.0000705","article-title":"Visceral leishmaniasis relapse in Southern Sudan (1999\u20132007): a retrospective study of risk factors and trends","volume":"4(6)","author":"S Gorski","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e1657","DOI":"10.1371\/journal.pntd.0001657","article-title":"Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis","volume":"6(5)","author":"V Bhandari","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/tmi.12025","article-title":"Adherence to miltefosine treatment for visceral leishmaniasis under routine conditions in Nepal","volume":"18","author":"S Uranw","year":"2013","journal-title":"Trop Med Int Health"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.4049\/jimmunol.174.8.4916","article-title":"Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis","volume":"174","author":"HW Murray","year":"2005","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Rai K, Cuypers B, Bhattarai NR, Uranw S, Berg M, <etal>et al<\/etal>. (2013) Relapse after treatment with miltefosine for Visceral Leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain. MBio. 4 doi:pii: e00611\u201313. 10.1128\/mBio.00611-13.","DOI":"10.1128\/mBio.00611-13"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2174\/138945006779025347","article-title":"Pharmacogenetics of cytochromes P450 in tropical medicine","volume":"7","author":"V Ribeiro","year":"2006","journal-title":"Curr Drug Targets"},{"key":"ref18","first-page":"436","article-title":"Differences in resistance against Kala-azar (Kenya strain) between males and females","volume":"21","author":"DJ Wijers","year":"1969","journal-title":"Trop Geogr Med"},{"key":"ref19","first-page":"277","article-title":"The effect of age and sex on incidence of Kala-azar","volume":"22","author":"MC Sharma","year":"1990","journal-title":"J Comm Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis","volume":"347","author":"S Sundar","year":"2002","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/519690","article-title":"Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis","volume":"196","author":"SK Bhattacharya","year":"2007","journal-title":"J Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/01.inf.0000066877.72624.cb","article-title":"Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis","volume":"22","author":"S Sundar","year":"2003","journal-title":"Pediatr J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"TP Dorlo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/AAC.00292-12","article-title":"Optimal dosing of miltefosine in children and adults with visceral leishmaniasis","volume":"56","author":"TP Dorlo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","article-title":"Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure","author":"TP Dorlo","year":"2014","journal-title":"J Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1086\/510860","article-title":"Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate","volume":"195","author":"A Cruz","year":"2007","journal-title":"J Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/0035-9203(85)90197-X","article-title":"Visceral leishmaniasis unresponsive to antimonial drugs. I. Clinical and immunological studies","volume":"79","author":"AD Bryceson","year":"1985","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.0141-9838.2004.00710.x","article-title":"Hormonal and immunological mechanisms mediating sex differences in parasite infection","volume":"26","author":"SL Klein","year":"2004","journal-title":"Parasite Immunology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0020-7519(96)80001-4","article-title":"Sex differences in parasite infections: patterns and processes","volume":"26","author":"M Zuk","year":"1996","journal-title":"Int J Parasitol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/infdis\/168.3.699","article-title":"Epidemiology of cutaneous leishmaniasis in Colombia: a longitudinal study of the natural history, prevalence, and incidence of infection and clinical manifestations","volume":"168","author":"KA Weigle","year":"1993","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0035-9203(95)90008-X","article-title":"Visceral leishmaniasis in Somalia: prevalence of markers of infection and disease manifestations in a village in an endemic area","volume":"89","author":"SA Shiddo","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/00365540410020451","article-title":"An emerging peri-urban pattern of infection with Leishmania chagasi, the protozoan causing visceral leishmaniasis in northeast Brazil","volume":"36","author":"SM Jeronimo","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000180265","article-title":"Sex hormones and modulation of immunity against leishmaniasis","volume":"16","author":"H Snider","year":"2009","journal-title":"Neuroimmunomodulation"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e62390","DOI":"10.1371\/journal.pone.0062390","article-title":"Sex bias in infectious disease epidemiology: patterns and processes","volume":"8(4)","author":"F Guerra-Silveira","year":"2013","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"S Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref36","first-page":"131","article-title":"Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar","volume":"18","author":"VN Das","year":"2005","journal-title":"Natl Med J India"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1542\/peds.2010-0082","article-title":"Clinical report\u2013guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations","volume":"125","author":"RE Shaddy","year":"2010","journal-title":"Pediatrics"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"TK Jha","year":"1999","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4269\/ajtmh.2011.10-0661","article-title":"Phase IV trial of miltefosine in adults and children for treatment of visceral leishmaniasis (kala-azar) in Bangladesh","volume":"85","author":"M Rahman","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1086\/380638","article-title":"Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India","volume":"38","author":"SK Bhattacharya","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/505217","article-title":"A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection","volume":"43","author":"K Ritmeijer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref42","first-page":"1076","article-title":"Miltefosine in children with visceral leishmaniasis","volume":"43","author":"UK Singh","year":"2006","journal-title":"Indian J Pediatr"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0100220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T05:42:12Z","timestamp":1540273332000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0100220"}},"subtitle":[],"editor":[{"given":"Lisa FP.","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,18]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0100220","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,18]]}}}